Covid 19 Aerosol Generating Medical Procedures
Covid 19 Aerosol Generating Medical Procedures
Covid 19 Aerosol Generating Medical Procedures
This document provides details about Aerosol Generating Medical Procedures (AGMPs) specifically with
regard to patients under investigation (PUI) for 2019 Novel Coronavirus (2019-nCoV). The Public Health
Agency of Canada has recommended that, in addition to routine precautions, healthcare workers
(HCWs) follow droplet and contact precautions when caring for patients meeting clinical and exposure
criteria for 2019-nCoV, unless performing an AGMP.
Patients with signs, symptoms and exposure criteria consistent with 2019-nCoV should be cared for
under droplet and contact precautions, unless an AGMP is required.
AGMPs that generate small droplet nuclei in high concentration present a risk for airborne transmission
of pathogens not otherwise able to spread by the airborne route (e.g., coronavirus, influenza). When
performing AGMPs for a PUI including for the purpose of specimen collection, it is recommended to
observe the following:
Place patient in an AIIR (airborne infection isolation room) if possible, or in a single room that
minimizes exposure to healthcare workers and other patients;
Limit the number of HCWs to only those required for the procedure;
Ensure HCWs performing or assisting with AGMP wear appropriate personal protective
equipment (PPE): gown, gloves, a fit tested N95 respirator and eye protection (i.e. face shield);
Observe appropriate hand hygiene, donning and doffing procedures.
IMPORTANT: this list is not exhaustive and includes common types of AGMPs. For scenarios not
described, please contact your local Infection Prevention and Control team and/or the Medical Health
Officer.
References:
https://www.cdc.gov/infectioncontrol/basics/transmission-based-precautions.html
https://www.picnet.ca/wp-content/uploads/Respiratory-Infection-Outbreak-Guidelines-for-Healthcare-
Facilities_November-2018.pdf
2019NCOV_AGMP_V2_February 7 2020